ING Group’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$303K Buy
4,257
+1,038
+32% +$81.9K ﹤0.01% 491
2025
Q4
$264K Buy
+3,219
New +$251K ﹤0.01% 537
2025
Q2
Sell
-327,449
Closed -$26.4M 520
2025
Q1
$26.4M Buy
327,449
+319,212
+3,875% +$27.4M 0.18% 91
2024
Q4
$644K Sell
8,237
-23,441
-74% -$1.99M ﹤0.01% 531
2024
Q3
$2.97M Buy
+31,678
New +$2.66M 0.02% 365
2024
Q2
Sell
-2,854
Closed -$259K 576
2024
Q1
$259K Buy
+2,854
New +$237K ﹤0.01% 545
2023
Q4
Sell
-3,268
Closed -$222K 593
2023
Q3
$222K Buy
+3,268
New +$238K ﹤0.01% 504
2023
Q2
Sell
-61,702
Closed -$5.06M 603
2023
Q1
$5.06M Buy
+61,702
New +$4.41M 0.05% 245

Other funds holding GEHC

ING Group's GEHC Position: Q1 2026 in Review

ING Group increased its GE HealthCare (GEHC) stake by 32% in Q1 2026, buying an estimated $81.9K and bringing the position to 4,257 shares worth $303K. The position accounts for ﹤0.01% of the portfolio, ranked #491.

ING Group first reported a position in GEHC in Q1 2023 and has held it in 8 quarters since. The position peaked at $26.4M in Q1 2025. 1,263 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • ING Group held 4,257 shares of GE HealthCare worth $303K as of Q1 2026.
  • ING Group bought 1,038 GE HealthCare shares in Q1 2026, an estimated $81.9K.
  • GE HealthCare made up ﹤0.01% of ING Group's portfolio in Q1 2026, its #491 holding.
  • ING Group first reported a position in GE HealthCare in Q1 2023 and has held it in 8 quarters since.
  • ING Group's GE HealthCare position peaked at $26.4M in Q1 2025.
  • 1,263 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on ING Group's 13F filing for Q1 2026, filed 11 May 2026.